Delivery Order SPE2DB22D2218-SPE2DB25FR2RR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Tresiba FlexTouch 200 unit/mL insulin pens in 3mL quantities, valued at $2,800.98. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was competitively awarded. The order is scheduled for completion by December 5, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,111.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on November 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a contract ceiling value of $1,932.96. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by October 31, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,152.60 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/ML in 3ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, with a ceiling value of $3,467.02 and a completion date of November 19, 2025. This is a firm fixed price delivery order issued without set-aside designation, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, valued at $2,411.94 with a completion date of October 30, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a direct fulfillment of medical supply needs through the federal pharmaceutical procurement system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,781.10. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,737.07 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/mL 3mL insulin pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tresiba FlexTouch 100 unit/mL insulin pens in 3mL quantities. This $2,146.80 firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $41,658.25 to supply Tresiba FlexTouch 100 Unit/mL in 3mL quantities. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR2RRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, valued at $11,182.92 under a firm fixed-price contract structure. This non-set-aside competitive award is positioned to be completed by June 3, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a procurement of insulin medication to support federal medical supply requirements, likely for military or veteran healthcare systems under the Defense Health Agency's purview. This delivery order is executed as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies globally to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, maintains a robust federal contract portfolio characterized by competitively awarded delivery orders with firm fixed pricing, demonstrating the company's capability to fulfill diverse federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 6/2/25 |